Anthem Biosciences Ltd, a CRDMO founded in 2006, offers end-to-end drug discovery-to-manufacturing services and specialises ...

The initial public offer of Anthem Biosciences received bids for 2,81,44,34,740 shares as against 4,40,70,682 shares on offer, according to stock exchange data at 17:30 IST on Wednesday (16 July 2025) ...

The key equity benchmarks continued to trade with moderate losses in mid-morning trade as investors remained cautious amid Donald Trump announced a 19% tariff on products that Indonesia sells to the ...

The key benchmark indices ended with small gains today, witnessing mild buying interest despite Donald Trump announced a 19% tariff on products that Indonesia sells to the United States. Further Trump ...

To distribute and promote Emcure's oral anti-diabetic (OAD) products in India Emcure Pharmaceuticals (Emcure) and Sanofi India (SIL) today entered into an exclusive distribution and promotion ...

Following the close of the subscription of initial public offering (IPO) of Anthem Biosciences Limited, all eyes of the ...